ScienceLatest
Spyre Therapeutics IBD drug shows promise in early trial
Spyre Therapeutics has reported positive results from an early trial of its drug for inflammatory bowel disease (IBD). The findings suggest potential effectiveness, paving the way for further research and development.
0 upvotes
What happened
Spyre Therapeutics has reported positive results from an early trial of its drug for inflammatory bowel disease (IBD).
Why it matters
The findings suggest potential effectiveness, paving the way for further research and development.